Opportunistic Bacteria: Potential Autoimmune Triggers
- Brady, David M. – Molecular Mimicry, the Hygiene Hypothesis, Stealth Infections and Other Examples of Disconnect between Medical Research and the Practice of Clinical Medicine in Autoimmune Disease. Open Journal of Rheumatology and Autoimmune Diseases 2013, 3, 33-39
- Brady, David M. – Autoimmune Disease: A Modern Epidemic? Townsend Letter June 2012;347:45-50
- Rashid T and Ebringer A. – Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune diseases. (2012)
- Mendelsohn et al., – Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. (2013)
H. pylori Virulence Factor References
- Role of dupA in virulence of Helicobacter pylori. (2016)
- Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. (2017)
- Helicobacter pylori BabA in adaptation for gastric colonization. (2017)
- Helicobacter pylori: A Paradigm Pathogen for Subverting Host Cell Signal Transmission. (2017)
- Pathogenesis of Helicobacter Pylori Infection (2016)
- Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease (2015)
- What exists beyond cagA and vacA? Helicobacter pylori genes in gastric diseases (2015)
- The significance of virulence factors in Helicobacter pylori (2013)
GI-MAP™ White Paper
In the last few decades, DNA analysis has transformed the field of GI testing. More than ever before, we are keenly aware of the health benefits and disease risks brought about by the microorganisms that inhabit the GI tract.
The GI Microbial Assay Plus (GI-MAP™) uses state-of-the-art qPCR technology to assess a patient’s microbiome from a single stool sample, with particular attention to microbes that cause disease or that disrupt normal microbial balance and contribute to perturbations in the GI microbiota and contribute to illness.
This white paper has been updated to include additional bacterial biomarkers introduced in July 2019. Read the GI-MAP White Paper and learn the science behind how DNA analysis can help your patients with gastrointestinal related symptoms.